Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Phase Ib Phase Ib stage: To determine the recommended dose (RD) of the combination of trabectedin and oxaliplatin in patients with advanced ovarian cancer. Phase II Phase II stage: To determine the antitumor activity of the combination of trabectedin and oxaliplatin, administered at the RD established in the phase Ib stage, in patients with advanced ovarian cancer.
Inclusion criteria
- Pretreated Advanced Ovarian Cancer